Long-term albumin infusion in decompensated cirrhosis: A review of current literature
| Autor: | Yu Jing Jonathan Chua, Rajesh Kumar, Yu Jun Wong, Tiing Leong Ang |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncotic pressure
medicine.medical_specialty Cirrhosis Gastroenterology 03 medical and health sciences 0302 clinical medicine Spontaneous bacterial peritonitis Hepatorenal syndrome Internal medicine medicine Paracentesis Hepatic encephalopathy Hepatology medicine.diagnostic_test business.industry Albumin Minireviews medicine.disease Acute-on-chronic liver failure Large-volume paracentesis 030220 oncology & carcinogenesis Portal hypertension 030211 gastroenterology & hepatology business |
| Zdroj: | World Journal of Hepatology |
| ISSN: | 1948-5182 |
| DOI: | 10.4254/wjh.v13.i4.421 |
| Popis: | Decompensated cirrhosis is characterized by chronic inflammation and severe portal hypertension leading to systemic circulatory dysfunction. Albumin infusion has been widely used in decompensated cirrhosis in patients with spontaneous bacterial peritonitis, large-volume paracentesis and hepatorenal syndrome. Emerging data suggest long-term albumin infusion has both oncotic and non-oncotic properties which may improve the clinical outcomes in decompensated cirrhosis patients. We review the current literature on both the established and potential role of albumin, and specifically address the controversies of long-term albumin infusion in decompensated cirrhosis patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|